SKI Market

A+| A| A-|

Indian Indices

Sensex

76,631.65 -931.25
( -1.20%)

Global Indices

Nasdaq

47,935.11 1,329.65
(2.85%)

Dow Jones

6,804.45 166.60
(2.51%)

Hang Seng

55,958.99 -349.43
(-0.62%)

Nikkei 225

10,596.41 247.62
(2.39%)

Forex

USD-INR

92.90 -0.03
(-0.03%)

EUR-INR

107.45 0.22
(0.21%)

GBP-INR

123.16 0.23
(0.18%)

JPY-INR

0.58 0.00
(-0.10%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Gopal Iron & Steels Co.(Gujarat) Ltd

Industry : Trading

BSE Code

ISIN Demat

Book Value()

531913

INE641H01018

1.8539383

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

7.67

EPS(TTM)

Face Value()

Div & Yield %

Back

emerald finserv ltd

Natco Pharma receives CDSCO approval for launch of Semaglutide in India

Feb 14,2026

Natco Pharma received approval for Semaglutide from Central Drugs Standard Control Organisation (CDSCO) to manufacture and market generic Semaglutide Injection in India. NATCO will launch the product in the India market in March'26.

Semaglutide is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise.

76,631.65 -931.25 ( -1.20%)

47,935.11 1,329.65 (2.85%)

6,804.45 166.60 (2.51%)

55,958.99 -349.43 (-0.62%)

10,596.41 247.62 (2.39%)

92.90 -0.03 (-0.03%)

107.45 0.22 (0.21%)

123.16 0.23 (0.18%)

0.58 0.00 (-0.10%)